SCHEMBL6538353

SCHEMBL6538353

Cc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1Oc1ccccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
HTT P42858 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
KDR P35968 1/20 0.41
TYK2 P29597 3/20 0.40
JAK2 O60674 2/20 0.40
JAK1 P23458 2/20 0.40
PABPC1 P11940 1/20 0.40
EIF4H Q15056 1/20 0.40
TP53 P04637 1/20 0.40
P2RY14 Q15391 1/20 0.39
POLB P06746 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.38
CASP3 P42574 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537592 0.87 KMT2A (0.44) MAPTHTTSMN1; SMN2LMNATSHR
SCHEMBL6537672 0.85 HTT (0.42) MAPTHTTSMN1; SMN2RAB9ALMNA
SCHEMBL6538202 0.85 RAB9A (0.42) MAPTHTTSMN1; SMN2NPC1RAB9A
SCHEMBL6537627 0.84 PTGS2 (0.43) MAPTHTTSMN1; SMN2NPC1RAB9A
SCHEMBL6538054 0.83 TYK2 (0.44) MAPTHTTSMN1; SMN2LMNATSHR
SCHEMBL6538040 0.83 MAPK10 (0.44) MAPTNPC1RAB9APOLBMEN1
SCHEMBL6536777 0.82 GAA (0.43) MAPTHTTSMN1; SMN2RAB9ALMNA
SCHEMBL6538368 0.82 P2RY14 (0.41) MAPTHTTSMN1; SMN2LMNATSHR
SCHEMBL6537570 0.82 POLB (0.44) MAPTHTTSMN1; SMN2NPC1RAB9A
SCHEMBL6537706 0.81 TYK2 (0.41) MAPTHTTSMN1; SMN2RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed